Nancy L. Keating, MD, MPH, is an associate professor of medicine and of health care policy at Harvard Medical School and an associate physician at Brigham and Women’s Hospital.

Dr. Keating’s research interests include the quality of care for patients at risk for and diagnosed with cancer, particularly breast cancer; health care at the interface of primary and specialty care; and communication between providers and patients and among providers. She is a recipient of a Doris Duke Clinical Scientist Award, an award of the Doris Duke Charitable Foundation that supports young investigators beginning their careers as independent clinical researchers. With support from this award, she has examined the contribution of providers of differing specialties to the diagnosis, treatment, and surveillance for women at risk for or once diagnosed with breast cancer. In related work, she has examined treatment decision making among women newly diagnosed with early-stage breast cancer, including the effect of discussing surgical treatment options for breast cancer with a medical oncologist on treatment decision making, patients’ desired and actual roles in decision making, and disclosure of treatment alternatives by surgeons.

In addition, Dr. Keating is currently an active participant in the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium, funded by the National Cancer Institute (NCI). This is a collaborative effort among investigators at seven sites to examine patterns of care and outcomes for patients with colorectal and lung cancer. Dr. Keating is also examining the quality of care delivered to patients diagnosed with cancer in the Veterans Administration health care system. Further, she has been funded by the NCI to examine long-term outcomes after breast cancer treatments in community populations of patients, and she is examining adverse effects of hormonal therapy used in the treatment of men with prostate cancer. In recent work, she has examined how managed care market share influences care provided to Medicare patients diagnosed with breast, colorectal, or prostate cancer who receive care in the fee-for-service sector.

Dr. Keating graduated summa cum laude from Virginia Tech. She received her MD degree from the University of Chicago, Pritzker School of Medicine, and her MPH degree from the Harvard School of Public Health.